Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease.

CONCLUSIONS: In M-ILD, AZA treatment was associated with improved FVC%, DLCO%, and prednisone dose. Patients treated with MMF had improved FVC% and prednisone dose. After 36 months, patients treated with AZA used a lower prednisone dose than those treated with MMF. PMID: 31238042 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31238042?dopt=Abstract

Source: Chest - June 21, 2019 Category: Respiratory Medicine Authors: Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Abanti S, Mammen AL, Christopher-Stine L, Danoff SK Tags: Chest Source Type: research

More News: Interstitial Lung Disease | Prednisone | Respiratory Medicine | Smokers | Study